Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP612371.RAEP3AH51XwVpbyr5AUlDuVpZ7c_1wzLkn3LxLdkHpHyI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP612371.RAEP3AH51XwVpbyr5AUlDuVpZ7c_1wzLkn3LxLdkHpHyI130_assertion type Assertion NP612371.RAEP3AH51XwVpbyr5AUlDuVpZ7c_1wzLkn3LxLdkHpHyI130_head.
- NP612371.RAEP3AH51XwVpbyr5AUlDuVpZ7c_1wzLkn3LxLdkHpHyI130_assertion wasGeneratedBy ECO_0000203 NP612371.RAEP3AH51XwVpbyr5AUlDuVpZ7c_1wzLkn3LxLdkHpHyI130_provenance.
- NP612371.RAEP3AH51XwVpbyr5AUlDuVpZ7c_1wzLkn3LxLdkHpHyI130_assertion wasDerivedFrom befree-20150227 NP612371.RAEP3AH51XwVpbyr5AUlDuVpZ7c_1wzLkn3LxLdkHpHyI130_provenance.
- NP612371.RAEP3AH51XwVpbyr5AUlDuVpZ7c_1wzLkn3LxLdkHpHyI130_assertion SIO_000772 23754492 NP612371.RAEP3AH51XwVpbyr5AUlDuVpZ7c_1wzLkn3LxLdkHpHyI130_provenance.
- NP612371.RAEP3AH51XwVpbyr5AUlDuVpZ7c_1wzLkn3LxLdkHpHyI130_assertion evidence source_evidence_literature NP612371.RAEP3AH51XwVpbyr5AUlDuVpZ7c_1wzLkn3LxLdkHpHyI130_provenance.
- NP612371.RAEP3AH51XwVpbyr5AUlDuVpZ7c_1wzLkn3LxLdkHpHyI130_assertion description "[Increasing the expression of cyclin-cyclin-dependent kinase inhibitors (cyclin-CDK) using small molecule inhibitors is a therapeutic strategy used to suppress cancer cell growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP612371.RAEP3AH51XwVpbyr5AUlDuVpZ7c_1wzLkn3LxLdkHpHyI130_provenance.